Non-CCONS Events

While the Columbus Chapter of the Oncology Nursing Society (CCONS) advertises these programs, it does not endorse or guarantee the content or views presented therein. Any opinions or positions expressed in the programs are solely those of the individuals involved and do not necessarily reflect those of the Columbus Chapter of the Oncology Nursing Society (CCONS). Please use your discretion when participating in a program.

Program Title: Safety and Administration of LYNOZYFIC

Date/Time: Tuesday, March 17, 2026 | 5:30 PM (ET)

Location: Mitchell's Steakhouse| 1408 Polaris Pkwy | Columbus, Ohio 43240

Host: Regeneron

RSVP/Contact: https://tpprod-regeneron.physiciansworld.com/4tOE32

SAFETY_AND_ADMINISTRATION_OF_LYNOZYFIC.pdf

Program Title: The Ohio State University Inaugural Multidisciplinary Neuro-Oncology Symposium

Date/Time: Saturday March 28, 2026 | 7:30AM-2:00PM

Location: Biomedical Research Tower Room 115 | 460 W 12th Ave | Columbus, Ohio 43210

Host: The Ohio State University

RSVP/Contact: Register by link (see link below) 

You must RSVP by March 15, 2026

Registration Link

Program Title: APP Oncology Summit & Oncology Nursing Summit

Date/Time: April 24-25, 2026

Location: The Westin Cincinnati Hotel | 21 E 5th St | Cincinnati, Ohio 45202

Host: APPOS

RSVP/Contact: Register by link (see link below) 

Early Bird Registration by February 24, 2026

Advanced Registration by March 24, 2026

General Registration through April 24, 2026

Both conferences offer CME credits, contact hours, and pharmacology hours. Registration for one conference grants access to both conferences. If you are a clinician, don’t forget to use code ONS@CINCI26$ code at checkout to get 30% off the registration fee!

Register for APP Oncology Summit

Register for Oncology Nursing Summit

Oncology_Nursing_Summit_2026_Cincinnati_CCONS.pdf

APPOS_2026_Cincinnati_CCONS.pdf

RESEARCH STUDY OPPORTUNITY - OHIO STATE UNIVERSITY

The Orchard Research Lab at The Ohio State University is currently conducting a research study to test the efficacy, sustainability & mechanisms of a 12-week MIND diet intervention to reduce cancer-related cognitive impairment, fatigue, & psychological symptoms in triple-negative breast cancer survivors. Participants (females age 40-65) who are within 12 months of starting initial systemic treatment for stage I-III triple-negative breast cancer (TNBC) will be randomized into either a dietary intervention group or to a general health coaching control, with those in the control group being able to cross over and receive the dietary intervention after completing the control arm. More information can be found on our website: https://u.osu.edu/orchard6/

Shared by Cindy Conway